Keyword Suggestion
Domain Informations
Aptevotherapeutics.com lookup results from whois.godaddy.com server:
- Domain created: 2015-09-25T19:34:48Z
- Domain updated: 2024-10-01T01:35:41Z
- Domain expires: 2025-09-25T19:34:48Z 0 Years, 273 Days left
- Website age: 9 Years, 92 Days
- Registrar Domain ID: 1963659931_DOMAIN_COM-VRSN
- Registrar Url: http://www.godaddy.com
- Registrar WHOIS Server: whois.godaddy.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: 480-624-2505
- Name server:
- NS15.DOMAINCONTROL.COM
- NS16.DOMAINCONTROL.COM
Network
- 0 : 23.254.128.0 - 23.254.255.255,HOSTWINDS-17-6,NET-23-254-128-0-1,Direct Allocation,2011-11-30,2024-11-25,Array
- 1 : Hostwinds Block-23.254.128.0/17,Hostwinds Seattle Network,23.254.128.0 - 23.254.255.255
Owner
- 0 : Hostwinds LLC.,HL-29,Array
- 1 : Hostwinds LLC
Technical support
- 0 : HNOC9-ARIN,Hostwinds Network Operations Center,+1-206-886-0665,[email protected]
- 1 : [email protected]
Abuse
- handle : HAC3-ARIN
- name : Hostwinds Abuse Center
- phone : +1-206-886-0665
- email : [email protected]
Administrator
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 23.254.131.60
- Location: Seattle United States
- Latitude: 47.4902
- Longitude: -122.3004
- Timezone: America/Los_Angeles
Site Inspections
Port Scanner (IP: 23.254.131.60)
Spam Check (IP: 23.254.131.60)
Email address with aptevotherapeutics.com
Recent Searched Sites
› Gardenhwyautoclinic.com (25 seconds ago) / US
› Thomasjefferson.edu.pe (2 seconds ago) / CA
› Trainz-mp.ru (28 seconds ago) / RU
› 443id.com (4 seconds ago) / US
› Mapleair.com (42 seconds ago) / US
› Fulijisuanqi.com (3 seconds ago) / US
› Aptevotherapeutics.com (0 seconds ago) / US
› Benzveen.com (10 seconds ago) / AU
› Myeaoron.ecwid.com (26 seconds ago) / US
› Berlin.nabu.de (1 mins ago) / DE
› Champsautoaz.com (22 seconds ago) / US
› Link.comhub.ru (8 seconds ago) / RU
› 2bresidential.com (12 seconds ago) / US
› Act-advisors.com (17 seconds ago) / US
› Fivensix.co.kr (18 seconds ago) / KR
› Movie2ufree.tv (43 seconds ago) / US
› Dem.ri.org (43 seconds ago) / US
› Edelman.com (17 seconds ago) / US
› Gmeg.kr (5 seconds ago) / KR
› Orders.psahelpline.ph (4 seconds ago) / US
Websites Listing
We found Websites Listing below when search with aptevotherapeutics.com on Search Engine
Home : Aptevo
Redefining the nature of biotech. Aptevo Therapeutics is not the usual biotech company. Our proprietary ADAPTIR™ (modular protein technology) platform, the most innovative minds in the field, and a culture of employee ownership empower us to advance the science of what’s next in oncology and hematology.
Aptevotherapeutics.comNews | Aptevo Therapeutics Inc
2022-03-24 · SEATTLE, WA / ACCESSWIRE / March 24, 2022 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today reported its financial results for. Read More.
Aptevotherapeutics.gcs-web.comPresentations | Aptevo Therapeutics Inc
2021-12-13 · Scientific Presentations (Aptevo at ASH 2021) Date. Documents. December 13, 2021. Tolerabillity and Single Agent Anti-Neplastic Activity of the CD3xCD123 Bispecific Antibody APV0436 in Patients with Relapsed/Refractory AML or MDS. December 13, 2021. Risk and Severity of Cytokine Release Syndrome in-Patients with Relapsed/Refractory (R/R) AML or ...
Aptevotherapeutics.gcs-web.comAptevo Therapeutics Inc | LinkedIn
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. We leverage the innovative ADAPTIR™ platform technology, a …
Linkedin.comAptevo Therapeutics (OTC:APVTW), News - Benzinga
Short Interest. Aptevo Therapeutics (OTC:APVTW), News. Aptevo Therapeutics (OTC: APVTW)
Benzinga.comAtossa Therapeutics - A Clinical-Stage Biopharmaceutical …
Atossa has two programs to develop therapies to treat COVID-19: One called the COVID-19 HOPE Program which uses AT-H201 for severely ill patients to improve lung function and reduce the amount of time that COVID-19 patients are on ventilators and another called AT-301 Nasal Spray for at-home use immediately following diagnosis of COVID-19 to ...
Atossatherapeutics.comWelcome - Innovative Physical Therapy and Wellness Studio
Everyone makes you feel that they are glad you are here! The attention to detail and individual attention created an always friendly, efficient and professional environment for my PT visits. The prompt service given by everyone was the best and always with a smile on their faces.
Innovativeptllc.comAptevo Therapeutics (OTC:APVTW), Guidance and Forecast
Aptevo Therapeutics (OTC:APVTW), Guidance and Forecast. Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a ...
Benzinga.comAptevo Therapeutics Inc. (APVO) Stock Price, News, Quote
SEATTLE, WA / ACCESSWIRE / March 24, 2022 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel …
Finance.yahoo.comAptevo Therapeutics (OTC:APVTW), Dividends - Benzinga
Aptevo Therapeutics issues dividends to shareholders from excess cash Aptevo Therapeutics generates. Most companies pay dividends on a quarterly basis, but dividends may also be …
Benzinga.comWorking at Aptevo Therapeutics | Glassdoor
Glassdoor gives you an inside look at what it's like to work at Aptevo Therapeutics, including salaries, reviews, office photos, and more. This is the Aptevo Therapeutics company profile. All content is posted anonymously by employees working at Aptevo Therapeutics.
Glassdoor.caAdept Therapeutics Inc. - Biotechnology Company, Beverly, MA
Your domain registration is pending. Check back in an hour. Adept Therapeutics Inc. Get Quote Call now Get directions Get Quote Call now Get directions
Adepttx.comAptevo Therapeutics (NasdaqCM:APVO) - Simply Wall St
2022-07-03 · Aptevo Therapeutics Receives Non-Compliance Letter from Nasdaq. On April 1, 2022, Aptevo Therapeutics Inc. (the ‘company’) received a letter from The Nasdaq Stock Market LLC (‘Nasdaq’) indicating that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market to maintain a minimum of …
Simplywall.stAptevo Therapeutics - HealthCare Royalty Partners
2021-03-31 · HCR purchased the right to receive all royalty payments made to Aptevo Therapeutics by Pfizer in respect of net sales of Ruxience. Aptevo monetized this non-strategic royalty interest to raise nondilutive capital to strengthen its financial position, providing additional capital cushion to fund its promising clinical programs and operations.
Healthcareroyalty.comGap Therapeutics :: Virginia (US) :: OpenCorporates
2019-05-01 · Free and open company data on Virginia (US) company Gap Therapeutics (company number 08439101), 737 N 5th St, Richmond, Virginia, 23219-1441
Opencorporates.comAPVO: Aptevo Therapeutics Inc - Stock Price, Quote and News
Aptevo Therapeutics Inc. is a clinical-stage, research and development biotechnology company. The Company is focused on developing immunotherapeutic candidates for the treatment of different forms ...
Cnbc.comReal Time Insider Data - DATAROMA - Investing
Purchase/Sale: Shares: Price $ Amount $ D/I: 03 Jun 2022 15:06: APVO: Aptevo Therapeutics Inc : NIEDERHUBER JOHN
Dataroma.comAptevo Therapeutics Inc盘中异动 大幅下挫5.37%
Aptevo Therapeutics Inc公司简介：Aptevo Therapeutics Inc是一家处于临床研究开发阶段的生物技术公司。它专注于开发用于治疗不同形式癌症的新型免疫治疗候选药物。其临床候选药物APVO436和前临床候选药物ALG.APV-527和APVO603是利用ADAPTIR模块蛋白技术平台开发的。ADAPTIR和 ...
Moomoo.comRebecca Gottschalk - Senior Scientist, Immunobiology - LinkedIn
Rebecca Gottschalk Senior Scientist, Immunobiology at Aptevo Therapeutics Inc Seattle, Washington, United States 352 connections
Linkedin.comTickeron on Twitter: "$APVO's in Uptrend: Moving Average …
$APVO's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for this and other indicators: https://srnk.us/go ...
Twitter.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| itecknologi.com | namecheap.com | -1 Years, -268 Days |
| craftofscientificposters.com | register.com | -1 Years, -241 Days |
| hash24.info | dynadot.com | -2 Years, -28 Days |
| scrapprecycling.com | godaddy.com | -1 Years, -218 Days |
| smsdroles.info | namecheap.com | -1 Years, -353 Days |
| cleverjourney.com | gandi.net | -1 Years, -235 Days |
| furuimedical.com | godaddy.com | -1 Years, -175 Days |
| hopegas.com | godaddy.com | -1 Years, -278 Days |
| desertpodiatry.com | register.com | -2 Years, -330 Days |
| ikido.tech | godaddy.com | -2 Years, -283 Days |